CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.3B
1-Year Est. Return 45.88%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+45.88%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.3B
AUM Growth
+$92.1M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
543
New
Increased
Reduced
Closed

Top Buys

1
+$16.2M
2
+$6.26M
3
+$4.07M
4
META icon
Meta Platforms (Facebook)
META
+$3.94M
5
RACE icon
Ferrari
RACE
+$2.98M

Top Sells

1
+$11.5M
2
+$7.75M
3
+$6.78M
4
ORCL icon
Oracle
ORCL
+$2.75M
5
RCL icon
Royal Caribbean
RCL
+$2.72M

Sector Composition

1 Technology 37.86%
2 Healthcare 22.63%
3 Communication Services 13.04%
4 Consumer Discretionary 10.29%
5 Consumer Staples 2.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ELVN icon
376
Enliven Therapeutics
ELVN
$1.79B
$149K 0.01%
9,671
-712
GOSS icon
377
Gossamer Bio
GOSS
$117M
$148K 0.01%
+47,716
KURA icon
378
Kura Oncology
KURA
$806M
$147K 0.01%
14,179
-1,035
MESO
379
Mesoblast
MESO
$2.03B
$144K 0.01%
7,992
-284
ESPR icon
380
Esperion Therapeutics
ESPR
$645M
$144K 0.01%
38,955
+3,614
CRVS icon
381
Corvus Pharmaceuticals
CRVS
$1.41B
$140K 0.01%
18,169
+5,108
GERN icon
382
Geron
GERN
$1.04B
$137K 0.01%
104,020
-7,815
VIR icon
383
Vir Biotechnology
VIR
$1.55B
$137K 0.01%
22,670
-1,680
ON icon
384
ON Semiconductor
ON
$23.5B
$135K 0.01%
2,500
-10,797
AVBP icon
385
ArriVent BioPharma
AVBP
$1.05B
$135K 0.01%
6,727
-384
JANX icon
386
Janux Therapeutics
JANX
$856M
$135K 0.01%
9,801
-733
KALV icon
387
KalVista Pharmaceuticals
KALV
$932M
$133K 0.01%
8,236
-588
ORIC icon
388
Oric Pharmaceuticals
ORIC
$1.41B
$130K 0.01%
15,870
-11,154
AQST icon
389
Aquestive Therapeutics
AQST
$512M
$128K 0.01%
19,880
-1,325
GHRS icon
390
GH Research
GHRS
$978M
$128K 0.01%
+10,107
RIGL icon
391
Rigel Pharmaceuticals
RIGL
$516M
$127K 0.01%
2,958
-186
TECX
392
Tectonic Therapeutic
TECX
$624M
$126K 0.01%
6,050
-830
PAHC icon
393
Phibro Animal Health
PAHC
$2.04B
$124K 0.01%
3,332
-238
REPL icon
394
Replimune Group
REPL
$680M
$124K 0.01%
12,782
-900
ARVN icon
395
Arvinas
ARVN
$885M
$124K 0.01%
10,465
-2,404
TMDX icon
396
Transmedics
TMDX
$4.49B
$122K 0.01%
1,000
ABSI icon
397
Absci
ABSI
$382M
$120K 0.01%
34,503
+8,294
RGNX icon
398
Regenxbio
RGNX
$501M
$119K 0.01%
8,249
-605
LXEO icon
399
Lexeo Therapeutics
LXEO
$526M
$118K 0.01%
11,893
+2,427
CTMX icon
400
CytomX Therapeutics
CTMX
$827M
$118K 0.01%
+27,609
14 15
16
17 18